

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | eosinophil chemotaxis (GO:0048245) | 9.38721196 |
| 2 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 9.06781732 |
| 3 | regulation of activation of Janus kinase activity (GO:0010533) | 8.54916217 |
| 4 | eosinophil migration (GO:0072677) | 8.45086658 |
| 5 | negative regulation by host of viral transcription (GO:0043922) | 8.34281152 |
| 6 | regulation of chronic inflammatory response (GO:0002676) | 8.01962928 |
| 7 | DNA deamination (GO:0045006) | 7.21447623 |
| 8 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 7.13923979 |
| 9 | regulation of mononuclear cell migration (GO:0071675) | 7.07261345 |
| 10 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 7.04859830 |
| 11 | monocyte chemotaxis (GO:0002548) | 6.93128837 |
| 12 | macrophage chemotaxis (GO:0048246) | 6.71179812 |
| 13 | regulation of regulatory T cell differentiation (GO:0045589) | 6.63409055 |
| 14 | regulation of macrophage chemotaxis (GO:0010758) | 6.54955924 |
| 15 | positive regulation of T cell chemotaxis (GO:0010820) | 6.45943102 |
| 16 | regulation of T cell chemotaxis (GO:0010819) | 6.45943102 |
| 17 | positive regulation of monocyte chemotaxis (GO:0090026) | 6.39132630 |
| 18 | regulation of lymphocyte chemotaxis (GO:1901623) | 6.25401906 |
| 19 | cellular response to interleukin-15 (GO:0071350) | 6.10836800 |
| 20 | positive regulation of T cell apoptotic process (GO:0070234) | 6.05100395 |
| 21 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 6.04314578 |
| 22 | negative regulation of T cell apoptotic process (GO:0070233) | 6.01242118 |
| 23 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.96545389 |
| 24 | positive regulation of translational initiation (GO:0045948) | 5.43816247 |
| 25 | response to interleukin-15 (GO:0070672) | 5.42272701 |
| 26 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.01696184 |
| 27 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.01696184 |
| 28 | dendritic cell chemotaxis (GO:0002407) | 4.95201331 |
| 29 | modulation by host of symbiont transcription (GO:0052472) | 4.90222421 |
| 30 | modulation by host of viral transcription (GO:0043921) | 4.90222421 |
| 31 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.81420671 |
| 32 | regulation of T cell tolerance induction (GO:0002664) | 4.78020152 |
| 33 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 4.77076783 |
| 34 | negative regulation of B cell proliferation (GO:0030889) | 4.69615397 |
| 35 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.69139337 |
| 36 | modulation of transcription in other organism involved in symbiotic interaction (GO:0052312) | 4.63173136 |
| 37 | granulocyte activation (GO:0036230) | 4.55973024 |
| 38 | positive regulation of lymphocyte migration (GO:2000403) | 4.54215686 |
| 39 | negative regulation of viral genome replication (GO:0045071) | 4.52161428 |
| 40 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.52159248 |
| 41 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.44255195 |
| 42 | positive thymic T cell selection (GO:0045059) | 4.39716605 |
| 43 | negative regulation of viral transcription (GO:0032897) | 4.34149377 |
| 44 | regulation of monocyte chemotaxis (GO:0090025) | 4.30829581 |
| 45 | positive regulation of tolerance induction (GO:0002645) | 4.29944349 |
| 46 | positive T cell selection (GO:0043368) | 4.26849778 |
| 47 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.25796864 |
| 48 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 4.10199170 |
| 49 | positive regulation of cell killing (GO:0031343) | 4.07216615 |
| 50 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.04567524 |
| 51 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.98916978 |
| 52 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.97300810 |
| 53 | regulation of T cell apoptotic process (GO:0070232) | 3.91695524 |
| 54 | regulation of tolerance induction (GO:0002643) | 3.86939621 |
| 55 | neutrophil activation (GO:0042119) | 3.86100091 |
| 56 | positive regulation of leukocyte apoptotic process (GO:2000108) | 3.84200068 |
| 57 | negative regulation of B cell activation (GO:0050869) | 3.83806565 |
| 58 | dendritic cell migration (GO:0036336) | 3.81687240 |
| 59 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.76922553 |
| 60 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 3.76400742 |
| 61 | T cell costimulation (GO:0031295) | 3.74220460 |
| 62 | lymphocyte costimulation (GO:0031294) | 3.70534300 |
| 63 | regulation of cell killing (GO:0031341) | 3.67773194 |
| 64 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.64279213 |
| 65 | positive regulation of T cell migration (GO:2000406) | 3.61889902 |
| 66 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.61248771 |
| 67 | regulation of lymphocyte migration (GO:2000401) | 3.60202851 |
| 68 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.58022258 |
| 69 | thymic T cell selection (GO:0045061) | 3.53549460 |
| 70 | regulation of calcium-mediated signaling (GO:0050848) | 3.49970019 |
| 71 | cellular defense response (GO:0006968) | 3.47559898 |
| 72 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.47520462 |
| 73 | nucleoside diphosphate catabolic process (GO:0009134) | 3.39292160 |
| 74 | regulation of T cell migration (GO:2000404) | 3.38707384 |
| 75 | membrane raft organization (GO:0031579) | 3.37281650 |
| 76 | positive regulation of viral genome replication (GO:0045070) | 3.36721756 |
| 77 | negative T cell selection (GO:0043383) | 3.36671803 |
| 78 | T cell migration (GO:0072678) | 3.29515527 |
| 79 | regulation of interleukin-8 secretion (GO:2000482) | 3.28834309 |
| 80 | DNA demethylation (GO:0080111) | 3.26896486 |
| 81 | negative regulation of T cell activation (GO:0050868) | 3.26687492 |
| 82 | modification by host of symbiont morphology or physiology (GO:0051851) | 3.22888509 |
| 83 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.21164955 |
| 84 | localization within membrane (GO:0051668) | 3.20719131 |
| 85 | regulation of viral genome replication (GO:0045069) | 3.17952190 |
| 86 | negative regulation of T cell differentiation (GO:0045581) | 3.17015781 |
| 87 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.12321121 |
| 88 | T cell receptor signaling pathway (GO:0050852) | 3.10457941 |
| 89 | T cell selection (GO:0045058) | 3.10372118 |
| 90 | actin nucleation (GO:0045010) | 3.08099443 |
| 91 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.08076521 |
| 92 | activated T cell proliferation (GO:0050798) | 3.05660804 |
| 93 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.05226586 |
| 94 | negative regulation of viral process (GO:0048525) | 3.01548144 |
| 95 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.00575343 |
| 96 | positive regulation of interleukin-4 production (GO:0032753) | 2.99415387 |
| 97 | chemokine-mediated signaling pathway (GO:0070098) | 2.97809689 |
| 98 | cytidine deamination (GO:0009972) | 10.0110299 |
| 99 | cytidine metabolic process (GO:0046087) | 10.0110299 |
| 100 | cytidine catabolic process (GO:0006216) | 10.0110299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.14690077 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.98247670 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.43129905 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.50046075 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.45785149 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.08957340 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.92977072 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 2.87150227 |
| 9 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.84687688 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.50814062 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.49352602 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.31432043 |
| 13 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.26596350 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.25305218 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15393802 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.02787467 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 14.3508722 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.94818818 |
| 19 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.90972983 |
| 20 | MAF_26560356_Chip-Seq_TH2_Human | 1.83775270 |
| 21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76077970 |
| 22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75006848 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.73452731 |
| 24 | UTX_26944678_Chip-Seq_JUKART_Human | 1.69024413 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66017714 |
| 26 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.63989109 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.60691727 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.58864269 |
| 29 | GATA3_26560356_Chip-Seq_TH2_Human | 1.49769579 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.48654240 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47550500 |
| 32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.43006510 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39113284 |
| 34 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.37210613 |
| 35 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.32664162 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.29680733 |
| 37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25516991 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.24329940 |
| 39 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.23060060 |
| 40 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.17545813 |
| 41 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16948063 |
| 42 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15900057 |
| 43 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.08844686 |
| 44 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.05974704 |
| 45 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.05467659 |
| 46 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.03859661 |
| 47 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.00893652 |
| 48 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99906985 |
| 49 | GATA3_26560356_Chip-Seq_TH1_Human | 0.98718183 |
| 50 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.98328723 |
| 51 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.98193156 |
| 52 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.96308841 |
| 53 | VDR_22108803_ChIP-Seq_LS180_Human | 0.94681606 |
| 54 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.94441367 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91281042 |
| 56 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.88189906 |
| 57 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.87641195 |
| 58 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.87155395 |
| 59 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86148336 |
| 60 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.86034420 |
| 61 | P300_27268052_Chip-Seq_Bcells_Human | 0.83066111 |
| 62 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.83005327 |
| 63 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.81417352 |
| 64 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.80119894 |
| 65 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.80073015 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 0.78684570 |
| 67 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.77248181 |
| 68 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.76720326 |
| 69 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.76663645 |
| 70 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.75724664 |
| 71 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.74157572 |
| 72 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.74028509 |
| 73 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.73730420 |
| 74 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.73507827 |
| 75 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.72929565 |
| 76 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71963733 |
| 77 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71921933 |
| 78 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.71644965 |
| 79 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.71403936 |
| 80 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.70969024 |
| 81 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.70736412 |
| 82 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.69734528 |
| 83 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.68279160 |
| 84 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67345288 |
| 85 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.66826731 |
| 86 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.66449433 |
| 87 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.66180135 |
| 88 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.65717203 |
| 89 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.63385225 |
| 90 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.63385225 |
| 91 | SA1_27219007_Chip-Seq_Bcells_Human | 0.63260776 |
| 92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.62903427 |
| 93 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.61498852 |
| 94 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.60185333 |
| 95 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.59870699 |
| 96 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.59849699 |
| 97 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.59744944 |
| 98 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.59715516 |
| 99 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.58497180 |
| 100 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.57727285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 7.75869181 |
| 2 | MP0006082_CNS_inflammation | 4.15987190 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.69095211 |
| 4 | MP0001873_stomach_inflammation | 3.41772551 |
| 5 | MP0009785_altered_susceptibility_to | 3.16022614 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.09491519 |
| 7 | MP0009333_abnormal_splenocyte_physiolog | 2.81687967 |
| 8 | MP0001800_abnormal_humoral_immune | 2.79457077 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.70625100 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.69773748 |
| 11 | MP0010307_abnormal_tumor_latency | 2.68936683 |
| 12 | MP0002723_abnormal_immune_serum | 2.64807078 |
| 13 | MP0003866_abnormal_defecation | 2.51975414 |
| 14 | MP0000569_abnormal_digit_pigmentation | 2.47029299 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.42727573 |
| 16 | MP0002877_abnormal_melanocyte_morpholog | 2.40477129 |
| 17 | MP0003045_fibrosis | 2.35862769 |
| 18 | MP0001819_abnormal_immune_cell | 2.35776800 |
| 19 | MP0002398_abnormal_bone_marrow | 2.19162549 |
| 20 | MP0005025_abnormal_response_to | 2.18642509 |
| 21 | MP0010155_abnormal_intestine_physiology | 2.18173147 |
| 22 | MP0001790_abnormal_immune_system | 2.16856558 |
| 23 | MP0005387_immune_system_phenotype | 2.16856558 |
| 24 | MP0004145_abnormal_muscle_electrophysio | 2.13247223 |
| 25 | MP0002163_abnormal_gland_morphology | 2.11873343 |
| 26 | MP0002405_respiratory_system_inflammati | 2.09520919 |
| 27 | MP0001188_hyperpigmentation | 2.01568567 |
| 28 | MP0002452_abnormal_antigen_presenting | 1.96959954 |
| 29 | MP0000716_abnormal_immune_system | 1.95620032 |
| 30 | MP0005310_abnormal_salivary_gland | 1.91508882 |
| 31 | MP0003786_premature_aging | 1.87291525 |
| 32 | MP0002933_joint_inflammation | 1.84453575 |
| 33 | MP0001853_heart_inflammation | 1.84314814 |
| 34 | MP0002722_abnormal_immune_system | 1.69032923 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.65329373 |
| 36 | MP0000703_abnormal_thymus_morphology | 1.63327840 |
| 37 | MP0000685_abnormal_immune_system | 1.62200429 |
| 38 | MP0002429_abnormal_blood_cell | 1.56253679 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.55581685 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.53091624 |
| 41 | MP0002277_abnormal_respiratory_mucosa | 1.48758685 |
| 42 | MP0003183_abnormal_peptide_metabolism | 1.45118658 |
| 43 | MP0003448_altered_tumor_morphology | 1.36363116 |
| 44 | MP0002419_abnormal_innate_immunity | 1.35602874 |
| 45 | MP0005174_abnormal_tail_pigmentation | 1.26715599 |
| 46 | MP0004147_increased_porphyrin_level | 1.23547636 |
| 47 | MP0005379_endocrine/exocrine_gland_phen | 1.22982075 |
| 48 | MP0003436_decreased_susceptibility_to | 1.19556052 |
| 49 | MP0003075_altered_response_to | 1.16787440 |
| 50 | MP0000920_abnormal_myelination | 1.14304734 |
| 51 | MP0002876_abnormal_thyroid_physiology | 1.14157320 |
| 52 | MP0002638_abnormal_pupillary_reflex | 1.13677557 |
| 53 | MP0004381_abnormal_hair_follicle | 1.10298318 |
| 54 | MP0009765_abnormal_xenobiotic_induced | 1.08708158 |
| 55 | MP0008469_abnormal_protein_level | 1.08229991 |
| 56 | MP0002909_abnormal_adrenal_gland | 1.06369505 |
| 57 | MP0000372_irregular_coat_pigmentation | 1.04281361 |
| 58 | MP0009763_increased_sensitivity_to | 1.03673257 |
| 59 | MP0001905_abnormal_dopamine_level | 1.00640037 |
| 60 | MP0000015_abnormal_ear_pigmentation | 0.91913484 |
| 61 | MP0001919_abnormal_reproductive_system | 0.88189041 |
| 62 | MP0005670_abnormal_white_adipose | 0.87986374 |
| 63 | MP0004947_skin_inflammation | 0.86671523 |
| 64 | MP0002166_altered_tumor_susceptibility | 0.86282498 |
| 65 | MP0001661_extended_life_span | 0.82544416 |
| 66 | MP0001727_abnormal_embryo_implantation | 0.77125494 |
| 67 | MP0002168_other_aberrant_phenotype | 0.76954316 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 0.76089068 |
| 69 | MP0002019_abnormal_tumor_incidence | 0.74898369 |
| 70 | MP0002095_abnormal_skin_pigmentation | 0.74875626 |
| 71 | MP0002693_abnormal_pancreas_physiology | 0.74327583 |
| 72 | MP0003878_abnormal_ear_physiology | 0.73747489 |
| 73 | MP0005377_hearing/vestibular/ear_phenot | 0.73747489 |
| 74 | MP0005075_abnormal_melanosome_morpholog | 0.70832189 |
| 75 | MP0002006_tumorigenesis | 0.70382886 |
| 76 | MP0008873_increased_physiological_sensi | 0.69903565 |
| 77 | MP0004185_abnormal_adipocyte_glucose | 0.68485057 |
| 78 | MP0008007_abnormal_cellular_replicative | 0.66683059 |
| 79 | MP0009643_abnormal_urine_homeostasis | 0.62077811 |
| 80 | MP0001191_abnormal_skin_condition | 0.61557640 |
| 81 | MP0000858_altered_metastatic_potential | 0.60310517 |
| 82 | MP0004134_abnormal_chest_morphology | 0.58636876 |
| 83 | MP0003011_delayed_dark_adaptation | 0.58352851 |
| 84 | MP0002234_abnormal_pharynx_morphology | 0.55465809 |
| 85 | MP0000343_altered_response_to | 0.54628428 |
| 86 | MP0003806_abnormal_nucleotide_metabolis | 0.54425353 |
| 87 | MP0002136_abnormal_kidney_physiology | 0.51061928 |
| 88 | MP0001243_abnormal_dermal_layer | 0.50741567 |
| 89 | MP0005645_abnormal_hypothalamus_physiol | 0.49589851 |
| 90 | MP0002733_abnormal_thermal_nociception | 0.49063682 |
| 91 | MP0004043_abnormal_pH_regulation | 0.47874571 |
| 92 | MP0005083_abnormal_biliary_tract | 0.47686670 |
| 93 | MP0005389_reproductive_system_phenotype | 0.47191202 |
| 94 | MP0002090_abnormal_vision | 0.47038910 |
| 95 | MP0009764_decreased_sensitivity_to | 0.43956067 |
| 96 | MP0002083_premature_death | 0.43554007 |
| 97 | MP0001542_abnormal_bone_strength | 0.43475734 |
| 98 | MP0000371_diluted_coat_color | 0.43390755 |
| 99 | MP0005165_increased_susceptibility_to | 0.42537802 |
| 100 | MP0001968_abnormal_touch/_nociception | 0.41017259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 9.76953521 |
| 2 | Abnormality of T cell number (HP:0011839) | 9.62778389 |
| 3 | Abnormality of T cells (HP:0002843) | 5.76667177 |
| 4 | Hypoproteinemia (HP:0003075) | 5.74371672 |
| 5 | Increased IgM level (HP:0003496) | 4.98859444 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.98718409 |
| 7 | Chronic diarrhea (HP:0002028) | 4.98684370 |
| 8 | IgG deficiency (HP:0004315) | 4.90426146 |
| 9 | Autoimmune hemolytic anemia (HP:0001890) | 4.77220077 |
| 10 | Abnormality of the prostate (HP:0008775) | 4.26742224 |
| 11 | Severe combined immunodeficiency (HP:0004430) | 4.04712964 |
| 12 | Ureteral stenosis (HP:0000071) | 3.97391197 |
| 13 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.84855369 |
| 14 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.84855369 |
| 15 | Recurrent viral infections (HP:0004429) | 3.81283737 |
| 16 | Abnormality of eosinophils (HP:0001879) | 3.76393327 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 3.74316038 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.74316038 |
| 19 | Ureteral obstruction (HP:0006000) | 3.61062418 |
| 20 | Stomatitis (HP:0010280) | 3.59541758 |
| 21 | Obstructive lung disease (HP:0006536) | 3.55386766 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.55386766 |
| 23 | Meningitis (HP:0001287) | 3.50528202 |
| 24 | Recurrent bronchitis (HP:0002837) | 3.50180141 |
| 25 | Thyroiditis (HP:0100646) | 3.49258334 |
| 26 | Cutaneous melanoma (HP:0012056) | 3.48695496 |
| 27 | Hypoplasia of the thymus (HP:0000778) | 3.38831381 |
| 28 | Autoimmune thrombocytopenia (HP:0001973) | 3.36978079 |
| 29 | Aplastic anemia (HP:0001915) | 3.34757327 |
| 30 | Hypoalbuminemia (HP:0003073) | 3.34600649 |
| 31 | Abnormal albumin level (HP:0012116) | 3.34600649 |
| 32 | Recurrent fungal infections (HP:0002841) | 3.26977900 |
| 33 | Combined immunodeficiency (HP:0005387) | 3.16882592 |
| 34 | Pustule (HP:0200039) | 3.16205281 |
| 35 | Gangrene (HP:0100758) | 3.11332529 |
| 36 | IgA deficiency (HP:0002720) | 3.04278569 |
| 37 | Encephalitis (HP:0002383) | 2.99807349 |
| 38 | Chest pain (HP:0100749) | 2.98832827 |
| 39 | Pulmonary infiltrates (HP:0002113) | 2.96200296 |
| 40 | Eosinophilia (HP:0001880) | 2.95810986 |
| 41 | Joint swelling (HP:0001386) | 2.92236554 |
| 42 | Hemoptysis (HP:0002105) | 2.91075671 |
| 43 | Hemiplegia (HP:0002301) | 2.89977046 |
| 44 | Leukocytosis (HP:0001974) | 2.87343551 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 2.85581249 |
| 46 | Granulocytopenia (HP:0001913) | 2.78881613 |
| 47 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.75547810 |
| 48 | Agammaglobulinemia (HP:0004432) | 2.74094216 |
| 49 | J-shaped sella turcica (HP:0002680) | 2.72703886 |
| 50 | Abnormality of macrophages (HP:0004311) | 2.72460525 |
| 51 | Vasculitis (HP:0002633) | 2.67543834 |
| 52 | Abnormality of the pleura (HP:0002103) | 2.60953993 |
| 53 | Recurrent skin infections (HP:0001581) | 2.60749086 |
| 54 | 3-Methylglutaconic aciduria (HP:0003535) | 2.59660173 |
| 55 | Pulmonary fibrosis (HP:0002206) | 2.52295399 |
| 56 | Squamous cell carcinoma (HP:0002860) | 2.51343827 |
| 57 | Lymphopenia (HP:0001888) | 2.44683025 |
| 58 | Melanoma (HP:0002861) | 2.44290172 |
| 59 | Abnormality of male internal genitalia (HP:0000022) | 2.43103517 |
| 60 | Bronchitis (HP:0012387) | 2.37877245 |
| 61 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.34958749 |
| 62 | Pulmonary embolism (HP:0002204) | 2.32634993 |
| 63 | Tetraplegia (HP:0002445) | 2.29048075 |
| 64 | IgM deficiency (HP:0002850) | 2.28599539 |
| 65 | Abnormality of B cell number (HP:0010975) | 2.19934068 |
| 66 | Recurrent abscess formation (HP:0002722) | 2.15700552 |
| 67 | Zonular cataract (HP:0010920) | 2.15296518 |
| 68 | Myositis (HP:0100614) | 2.14554491 |
| 69 | Entropion (HP:0000621) | 2.12495430 |
| 70 | Recurrent bacterial skin infections (HP:0005406) | 2.12045439 |
| 71 | Abnormality of the pericardium (HP:0001697) | 2.06970547 |
| 72 | Hepatosplenomegaly (HP:0001433) | 2.04277402 |
| 73 | Skin rash (HP:0000988) | 2.03891562 |
| 74 | Recurrent otitis media (HP:0000403) | 2.03219322 |
| 75 | Molar tooth sign on MRI (HP:0002419) | 1.98062276 |
| 76 | Abnormality of midbrain morphology (HP:0002418) | 1.98062276 |
| 77 | Carpal bone hypoplasia (HP:0001498) | 1.96551391 |
| 78 | Polyneuropathy (HP:0001271) | 1.96452694 |
| 79 | Lymphoma (HP:0002665) | 1.95361990 |
| 80 | Keratitis (HP:0000491) | 1.95015261 |
| 81 | Recurrent corneal erosions (HP:0000495) | 1.94771653 |
| 82 | Gastrointestinal infarctions (HP:0005244) | 1.93427782 |
| 83 | Increased intramyocellular lipid droplets (HP:0012240) | 1.93029842 |
| 84 | Retinopathy (HP:0000488) | 1.92793541 |
| 85 | Panhypogammaglobulinemia (HP:0003139) | 1.91038225 |
| 86 | Increased serum ferritin (HP:0003281) | 1.90095082 |
| 87 | Acute hepatic failure (HP:0006554) | 1.89898909 |
| 88 | Optic neuritis (HP:0100653) | 1.87722413 |
| 89 | Retrobulbar optic neuritis (HP:0100654) | 1.87722413 |
| 90 | Abnormality of DNA repair (HP:0003254) | 1.85424467 |
| 91 | Visual hallucinations (HP:0002367) | 1.83007430 |
| 92 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.81806856 |
| 93 | Acute necrotizing encephalopathy (HP:0006965) | 1.81724043 |
| 94 | Periorbital edema (HP:0100539) | 1.81375220 |
| 95 | Abnormality of the alveolar ridges (HP:0006477) | 1.81278113 |
| 96 | Pancreatitis (HP:0001733) | 1.80374338 |
| 97 | Hypochromic anemia (HP:0001931) | 1.77890634 |
| 98 | Facial edema (HP:0000282) | 1.76702065 |
| 99 | Glomerulopathy (HP:0100820) | 1.75829801 |
| 100 | Focal motor seizures (HP:0011153) | 1.70045841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 4.20360278 |
| 2 | ITK | 2.72343541 |
| 3 | MAP4K1 | 2.49921151 |
| 4 | GRK7 | 2.38332108 |
| 5 | FES | 2.24588552 |
| 6 | PRKCQ | 2.06658379 |
| 7 | MAPKAPK3 | 2.02963435 |
| 8 | ADRBK2 | 2.02804512 |
| 9 | TXK | 11.5260531 |
| 10 | CSK | 1.96549691 |
| 11 | BUB1 | 1.89209562 |
| 12 | DAPK2 | 1.77115783 |
| 13 | BCKDK | 1.69855955 |
| 14 | LCK | 1.67127313 |
| 15 | TESK2 | 1.66227056 |
| 16 | WNK4 | 1.58600117 |
| 17 | TYRO3 | 1.55635866 |
| 18 | SYK | 1.55281684 |
| 19 | NTRK1 | 1.48374049 |
| 20 | MATK | 1.34389393 |
| 21 | ZAP70 | 1.22097090 |
| 22 | PIK3CA | 1.19749462 |
| 23 | BCR | 1.19644754 |
| 24 | TEC | 1.17243494 |
| 25 | NME1 | 1.14303043 |
| 26 | TBK1 | 1.13641370 |
| 27 | VRK2 | 1.08167035 |
| 28 | IKBKE | 1.06994649 |
| 29 | JAK3 | 1.05499052 |
| 30 | DAPK1 | 0.98230102 |
| 31 | MST4 | 0.90204438 |
| 32 | ZAK | 0.88408789 |
| 33 | PIM2 | 0.87733990 |
| 34 | BTK | 0.86922549 |
| 35 | IKBKB | 0.86310383 |
| 36 | JAK2 | 0.85126051 |
| 37 | MAP3K11 | 0.83405034 |
| 38 | NUAK1 | 0.81864290 |
| 39 | TRIM28 | 0.77313753 |
| 40 | FYN | 0.76739600 |
| 41 | VRK1 | 0.73427498 |
| 42 | LYN | 0.68652910 |
| 43 | GRK6 | 0.67740142 |
| 44 | PDGFRB | 0.67579069 |
| 45 | PIM1 | 0.66961044 |
| 46 | RIPK4 | 0.63605007 |
| 47 | CAMKK2 | 0.63397536 |
| 48 | FGFR1 | 0.63239340 |
| 49 | MAP4K2 | 0.62645617 |
| 50 | PIK3CG | 0.60742122 |
| 51 | GRK1 | 0.60219688 |
| 52 | CSF1R | 0.59649013 |
| 53 | MAP3K12 | 0.59472030 |
| 54 | CLK1 | 0.58882773 |
| 55 | MYLK | 0.53579978 |
| 56 | SCYL2 | 0.51515859 |
| 57 | ARAF | 0.51074877 |
| 58 | STK10 | 0.50496796 |
| 59 | OXSR1 | 0.49254137 |
| 60 | IRAK3 | 0.49133906 |
| 61 | LIMK1 | 0.48370520 |
| 62 | PDK1 | 0.47166151 |
| 63 | BLK | 0.46636203 |
| 64 | IRAK4 | 0.44319436 |
| 65 | INSR | 0.42991015 |
| 66 | MAPKAPK2 | 0.41040664 |
| 67 | MAPK11 | 0.39061164 |
| 68 | FRK | 0.38279909 |
| 69 | TLK1 | 0.38032109 |
| 70 | SRPK1 | 0.38014041 |
| 71 | CAMK2A | 0.37919754 |
| 72 | MAP3K6 | 0.36460244 |
| 73 | TAOK3 | 0.36052361 |
| 74 | IGF1R | 0.34960224 |
| 75 | TIE1 | 0.34139245 |
| 76 | MAP2K6 | 0.34099727 |
| 77 | BMPR2 | 0.32691489 |
| 78 | ROCK1 | 0.29487005 |
| 79 | ATR | 0.27992683 |
| 80 | PRKCA | 0.27602879 |
| 81 | PDK2 | 0.26913622 |
| 82 | GRK5 | 0.25009514 |
| 83 | AURKA | 0.22725487 |
| 84 | MAP3K14 | 0.21818963 |
| 85 | MELK | 0.21475516 |
| 86 | PRKACA | 0.21173360 |
| 87 | CAMK2D | 0.21126134 |
| 88 | OBSCN | 0.21026364 |
| 89 | TESK1 | 0.20514844 |
| 90 | TGFBR2 | 0.20205322 |
| 91 | CAMK2G | 0.20170437 |
| 92 | CSNK1A1 | 0.19972909 |
| 93 | MAPK3 | 0.19910522 |
| 94 | MAP3K7 | 0.19840162 |
| 95 | PDPK1 | 0.18794773 |
| 96 | CSNK1G3 | 0.18492685 |
| 97 | RPS6KA5 | 0.18287942 |
| 98 | PRKCB | 0.17701594 |
| 99 | INSRR | 0.17450104 |
| 100 | ABL1 | 0.14009101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.21770296 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.38392662 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.89566831 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.70016767 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.63344210 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.47441719 |
| 7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.37062126 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.13075394 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.12196085 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 3.08565629 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.88010790 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 2.76924802 |
| 13 | Measles_Homo sapiens_hsa05162 | 2.04126049 |
| 14 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.99895960 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.96581708 |
| 16 | Prion diseases_Homo sapiens_hsa05020 | 1.96098025 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.95222322 |
| 18 | Salmonella infection_Homo sapiens_hsa05132 | 1.82457195 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75164605 |
| 20 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.74687762 |
| 21 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.61822514 |
| 22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.54461829 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.49468911 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36178087 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.35388395 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.28770722 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.22011639 |
| 28 | Parkinsons disease_Homo sapiens_hsa05012 | 1.13506511 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.05846292 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94568493 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 0.84318022 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.79152452 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78808778 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 0.78241268 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77290537 |
| 36 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.77029693 |
| 37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72708275 |
| 38 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.71987197 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71686486 |
| 40 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70706765 |
| 41 | Leishmaniasis_Homo sapiens_hsa05140 | 0.69707575 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67613108 |
| 43 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66601767 |
| 44 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65940292 |
| 45 | Alzheimers disease_Homo sapiens_hsa05010 | 0.64708672 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 0.64160201 |
| 47 | Malaria_Homo sapiens_hsa05144 | 0.62932647 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61931973 |
| 49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.61257781 |
| 50 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61243465 |
| 51 | Protein export_Homo sapiens_hsa03060 | 0.53230161 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51657623 |
| 53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.50719235 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45823979 |
| 55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43400984 |
| 56 | RNA polymerase_Homo sapiens_hsa03020 | 0.41015381 |
| 57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39751040 |
| 58 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.39730622 |
| 59 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.39605009 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39501120 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.35883108 |
| 62 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.35808257 |
| 63 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.34823334 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 0.34320080 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32522204 |
| 66 | Huntingtons disease_Homo sapiens_hsa05016 | 0.28176344 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 0.27809096 |
| 68 | Tuberculosis_Homo sapiens_hsa05152 | 0.25293850 |
| 69 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.24064350 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.22949344 |
| 71 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.21966290 |
| 72 | Lysosome_Homo sapiens_hsa04142 | 0.21033114 |
| 73 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.20868966 |
| 74 | Phototransduction_Homo sapiens_hsa04744 | 0.20565517 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.20449705 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.19887155 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.19364398 |
| 78 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.17594242 |
| 79 | Homologous recombination_Homo sapiens_hsa03440 | 0.16841565 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.16521359 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.14224584 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.13483653 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.12101155 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.11226747 |
| 85 | Purine metabolism_Homo sapiens_hsa00230 | 0.11041976 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.09618315 |
| 87 | Alcoholism_Homo sapiens_hsa05034 | 0.06920760 |
| 88 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.06118888 |
| 89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.05683607 |
| 90 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.03425961 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.02603398 |
| 92 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.02286035 |
| 93 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.02039911 |
| 94 | RNA degradation_Homo sapiens_hsa03018 | 0.01745925 |
| 95 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.01560928 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.00991030 |
| 97 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.00678633 |
| 98 | Pertussis_Homo sapiens_hsa05133 | -0.0478184 |
| 99 | Propanoate metabolism_Homo sapiens_hsa00640 | -0.0422724 |
| 100 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | -0.0353899 |

